Clinical trials
Lymphoma trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 8 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| National Taiwan University Hospital | 3 |
| Genmab | 2 |
| Janssen Research & Development, LLC | 2 |
| Loxo Oncology, Inc. | 2 |
| National Health Research Institutes, Taiwan | 2 |
| Pfizer | 2 |
| ADC Therapeutics S.A. | 1 |
| Acerta Pharma BV | 1 |
| Anwita Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 40 |
| Lymphoma, Non-Hodgkin | 12 |
| Neoplasms | 8 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Hodgkin Disease | 4 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Follicular | 4 |
| Breast Neoplasms | 3 |
| Hematologic Diseases | 3 |
Trials
Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.